References

Recurrence of FSGS after kidney transplantation in adults

10.2215/cjn.08970719 · 2020 · External reference

KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation

10.1097/tp.0000000000003136 · 2020 · External reference

Long-term outcome of kidney transplantation in recipients with focal segmental glomerulosclerosis

10.2215/cjn.03060316 · 2016 · External reference

Recurrent and de novo focal segmental glomerulosclerosis after kidney transplantation: comparison of clinical features and transplant outcomes

10.1016/j.transproceed.2024.08.026 · 2024 · External reference

Combined rituximab and plasmapheresis or plasma exchange for focal segmental glomerulosclerosis in adult kidney transplant recipients: a meta-analysis

10.1007/s11255-020-02462-6 · 2020 · External reference

Rescue with obinutuzumab and daratumumab as combined B cell/plasma cell targeting approach in severe posttransplant focal segmental glomerulosclerosis recurrence

10.1016/j.ajt.2024.06.010 · 2024 · External reference

Efficacy of combined rituximab and daratumumab treatment in posttransplant recurrent focal segmental glomerulosclerosis

10.1016/j.ajt.2023.12.010 · 2024 · External reference

Post-transplant recurrence of focal segmental glomerulosclerosis in a child with heterozygous mutations in NPHS1 and NPHS2

10.1111/1744-9987.12443 · 2016 · External reference

Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma

10.1186/s13045-016-0283-0 · 2016 · External reference

CD38 and anti-CD38 monoclonal antibodies in AL amyloidosis: targeting plasma cells and beyond

10.3390/ijms21114129 · 2020 · External reference

Evolving understandings for the roles of CD38 protein in autoimmunity and autoimmune disease

10.1093/cei/uxag014 · 2026 · External reference

A randomized phase 2 trial of felzartamab in antibody-mediated rejection

10.1056/nejmoa2400763 · 2024 · External reference

Roles and crosstalks of macrophages in diabetic nephropathy

2022 · External reference

CASK, the soluble glomerular permeability factor, is secreted by macrophages in patients with recurrent focal and segmental glomerulo-sclerosis

10.3389/fimmu.2020.00875 · 2020 · External reference

Twist1 in podocytes ameliorates podocyte injury and proteinuria by limiting CCL2-dependent macrophage infiltration

10.1172/jci.insight.148109 · 2021 · External reference

CD38: a significant regulator of macrophage function

2022 · External reference

Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial

10.1016/s2352-3026(20)30070-3 · 2020 · External reference

Anti-CD38 daratumumab treatment of chronic active antibody-mediated kidney allograft rejection

10.1016/j.ekir.2025.07.009 · 2025 · External reference

Exome analysis resolves differential diagnosis of familial kidney disease and uncovers a potential confounding variant

10.1017/s0016672313000220 · 2013 · External reference

Nephrotic syndrome with mutations in NPHS2: the role of R229Q and implications for genetic counseling

10.1053/j.ajkd.2018.06.034 · 2019 · External reference

Recurrent FSGS post-kidney transplantations: where do we stand?

10.1097/tp.0000000000005335 · 2026 · External reference

Efficacy and safety of bleselumab in preventing the recurrence of primary focal segmental glomerulosclerosis in kidney transplant recipients: a phase 2a, randomized, multicenter study

10.1097/tp.0000000000004985 · 2024 · External reference